16:00 - 17:30
370: Graft rejection and other immunological complications
Oral session
Room: Pasquier
Chair/s:
Kareem Abu-Elmagd, Lorenzo Norsa
16:00 - 16:20
LATE  REFERRALS AND SENSITIZED PATIENTS
Robert Venick, USA
16:20 - 16:40
TAILORED IMMUNOSUPPRESSION
Laurens Ceulemans, Belgium
16:40 - 17:00
IBD-LIKE DISEASE: DIAGNOSIS, TREATMENT.
Francisco Hernandez, Spain
17:00 - 17:10
DISCUSSION
Post-transplant ulcerative ileitis (PTUI): risk factors and outcomes
Elsadig Hussan, Stuart Kaufman, Ahmed Elsabbagh, Khalid Khan, Nada Yazigi, Jason Hawksworth, Alexander Kroemer, Sukanya Subramanian, Thomas Fishbein, Cal Matsumoto
MedStar Georgetown Transplant Institute
The Role of T helper 17 cells in Severe Intestinal Transplant Rejection Renders it a Third Form of Inflammatory Bowel Disease
Leonid Belyayev 1, 2, Mohammed Sadat 2, Khalid Khan 2, Jason Hawksworth 2, Cal Matsumoto 2, Thomas Fishbein 2, Stuart Kaufman 2, Sukanya Subramanian 2, Jiman Kang 2, Alexander Kroemer 2
1 Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889, 2 MedStar Georgetown Transplant Institute, Georgetown University Hospital, 3800 Reservoir Road NW, Washington, DC 20007
Effectiveness of Infliximab therapy following intestinal transplantation 
Robert Venick 1, 2, Arpit Amin 2, Elizabeth Marcus 1, Marjorie Manchandia 1, Jorge Vargas 1, Ronald Busuttil 2, Douglas G Farmer 2
1 Pediatrics, David Geffen School of Medicine, UCLA, 2 Surgery, David Geffen School of Medicine, UCLA